|
MRK's Revenue Growth by Quarter and Year
Merck And Co Inc 's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| MRK Revenue (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
12,068.00
|
12,514.00
|
11,867.00
|
| III Quarter |
September |
-
|
13,154.00
|
12,551.00
|
12,397.00
|
| II Quarter |
June |
-
|
11,402.00
|
10,872.00
|
11,760.00
|
| I Quarter |
March |
15,901.00
|
12,080.00
|
12,057.00
|
10,816.00
|
| FY |
|
15,901.00
|
48,704.00
|
47,994.00
|
46,840.00
|
| MRK Revenue first quarter 2022 Y/Y Growth Comment |
Merck and Co Inc achieved in the first quarter 2022, above Company average Revenue growth of 31.63% year on year, to $ 15,901.00 millions.
Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 22 other companies have achieved higher Revenue growth. While Merck And Co Inc ' s Revenue rise of 31.63% ranks overall at the positon no. 403 in the first quarter 2022.
|
| MRK Revenue ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-3.56 % |
5.45 % |
7.9 % |
| III Quarter |
September |
- |
4.8 % |
1.24 % |
14.85 % |
| II Quarter |
June |
- |
4.87 % |
-7.55 % |
12.37 % |
| I Quarter |
March |
31.63 % |
0.19 % |
11.47 % |
7.76 % |
| FY |
|
- |
1.48 % |
2.46 % |
10.75 % |
MRK Revenue (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-8.26 % |
-0.29 % |
-4.28 % |
| III Quarter |
September |
- |
15.37 % |
15.44 % |
5.42 % |
| II Quarter |
June |
- |
-5.61 % |
-9.83 % |
8.73 % |
| I Quarter |
March |
31.76 % |
-3.47 % |
1.6 % |
-1.65 % |
| FY (Year on Year) |
|
- |
1.48 % |
2.46 % |
10.75 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 72.65 % |
1.79 % |
-47.74 % |
| (Dec 31 2013) |
|
(Sep. 30, 2015) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 72.65 % |
1.79 % |
-47.74 % |
| (Dec 31 2013) |
|
(Sep. 30, 2015) |
|
| Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Merck And Co Inc 's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 66.84 % |
1.88 % |
-10.73 % |
| (Dec. 30, 2009) |
|
|
| MRK's I. Quarter Q/Q Revenue Comment |
Merck and Co Inc achieved in the I. Quarter 2022 above company average sequential Revenue jump of 31.76%, to $ 15,901.00 millions, from $12,068.00 millions in the forth quarter.
Merck And Co Inc is impressively improving, not only reporting above normal increase, but also improving rate, Luca Ferrari, market expert mentioned.
Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 111. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 66.84 % |
1.88 % |
-10.73 % |
| (Dec. 30, 2009) |
|
|
| MRK's I. Quarter Q/Q Revenue Comment |
Merck and Co Inc achieved in the I. Quarter 2022 above company average sequential Revenue jump of 31.76%, to $ 15,901.00 millions, from $12,068.00 millions in the forth quarter.
Merck And Co Inc is going from strength to strength, with recording higher then normal gain, but also increasing speed.
Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Merck And Co Inc 's Revenue growth quarter on quarter, overall rank is 111. |
|
Merck And Co Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
12 Months Ending
(Jun 30 2021) |
12 Months Ending
(Mar 31 2021) |
| Cumulative Revenue 12 Months Ending |
$ 52,525.00 |
$ 48,704.00 |
$ 49,150.00 |
$ 48,547.00 |
$ 48,017.00 |
| Y / Y Revenue Growth (TTM) |
9.39 % |
1.48 % |
3.81 % |
2.87 % |
-0.13 % |
| Year on Year Revenue Growth Overall
Ranking |
# 1277 |
# 2969 |
# 2561 |
# 1814 |
# 1921 |
| Seqeuential Revenue Change (TTM) |
7.85 % |
-0.91 % |
1.24 % |
1.1 % |
0.05 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 403 |
# 1736 |
# 2696 |
# 3013 |
# 2642 |
| Cumulative Revenue growth
Comment |
Merck And Co Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 9.39% year on year, to $ 52,525 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Revenue growth was higher than company's average 6.99% and higher than 1.48% growth in Dec 31 2021.
But sequential increase was slower at 7.85 % from $48704 millions recorded in the period from Dec 31 2021 to Mar 31 2021.
Yet this was confirmation of positive momentum, as the usual sequential Revenue advancement stands at 1.79%.
The momentum is even higher from twelve months ended Dec 31 2021 showed at 7.85 % increase from $48704 millions in twelve months ending a quarter Dec 31 2021.
In the Healthcare sector 144 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1277, from total ranking in previous quarter at 2969. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
72.65 % |
1.79 % |
-47.74 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
88.24 % |
6.99 % |
-7.58 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 23 |
| Sector |
# 55 |
| S&P 500 |
# 403 |
|
| Cumulative Revenue growth
Comment |
Merck And Co Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 9.39% year on year, to $ 52,525 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Revenue growth was higher than company's average 6.99% and higher than 1.48% growth in Dec 31 2021.
But sequential increase was less at 7.85 % from $48704 millions reported in twelve months ending a quarter Dec 31 2021 Luca Ferrari added on.
In spite of, this was validation of strength, while the average sequential gain is at 1.79%.
The momentum was even stronger sequentially exhibited at 7.85 % jump from $48704 millions in the period from Dec 31 2021 to Mar 31 2021.
In the Healthcare sector 144 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1277, from total ranking in previous quarter at 2969. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
72.65 % |
1.79 % |
-47.74 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
88.24 % |
6.99 % |
-7.58 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 23 |
| Sector |
# 55 |
| S&P 500 |
# 403 |
|
54.23%